Tandem Diabetes Care, Inc. logo

TNDM

Tandem Diabetes Care, Inc.

$42.84

Earnings Summary

Revenue
$191.67Mn
Net Profits
$-42.72Mn
Net Profit Margins
-22.29%

Highlights

Revenue:

Tandem Diabetes Care, Inc.’s revenue jumped 13.16% since last year same period to $191.67Mn in the Q1 2024. On a quarterly growth basis, Tandem Diabetes Care, Inc. has generated -2.6% fall in its revenue since last 3-months.

Net Profits:

Tandem Diabetes Care, Inc.’s net profit jumped 65.52% since last year same period to $-42.72Mn in the Q1 2024. On a quarterly growth basis, Tandem Diabetes Care, Inc. has generated -42.37% fall in its net profits since last 3-months.

Net Profit Margins:

Tandem Diabetes Care, Inc.’s net profit margin jumped 69.53% since last year same period to -22.29% in the Q1 2024. On a quarterly growth basis, Tandem Diabetes Care, Inc. has generated -46.18% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Tandem Diabetes Care, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
-0.54
EPS Estimate Current Year
-0.54

Highlights

EPS Estimate Current Quarter:

Tandem Diabetes Care, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.54 - a 28.95% jump from last quarter’s estimates.

EPS Estimate Current Year:

Tandem Diabetes Care, Inc.’s earning per share (EPS) estimates for the current year stand at -0.54.

Key Ratios

Key ratios of the Tandem Diabetes Care, Inc. post its Q1 2024 earnings

Earning Per Share (EPS)
-0.63
Return on Assets (ROA)
-0.1
Return on Equity (ROE)
-0.49

Highlights

Earning Per Share (EPS):

Tandem Diabetes Care, Inc.’s earning per share (EPS) jumped 67.19% since last year same period to -0.63 in the Q1 2024. This indicates that the Tandem Diabetes Care, Inc. has generated 67.19% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Tandem Diabetes Care, Inc.’s return on assets (ROA) stands at -0.1.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Tandem Diabetes Care, Inc.’s return on equity (ROE) stands at -0.49.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-02
-0.76
-0.63
17.11%

Discover More Earning Stocks in Health Technology Sector